Rhumbline Advisers Chimerix Inc Transaction History

Rhumbline Advisers

  • $104 Billion
  • Q1 2025

A detailed history of Rhumbline Advisers transactions in Chimerix Inc stock. As of the latest transaction made, Rhumbline Advisers holds 2,005 shares of CMRX stock, worth $17,122. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,005
Holding current value
$17,122
% of portfolio
0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 08, 2025
BUY
$3.25 - $8.51 $6,516 - $17,062
2,005 New
2,005 $17,000
Q2 2024

Aug 01, 2024
SELL
$0.87 - $1.05 $1,445 - $1,744
-1,661 Reduced 30.81%
3,730 $3,000
Q3 2023

Nov 09, 2023
SELL
$0.94 - $1.23 $5,399 - $7,065
-5,744 Reduced 51.59%
5,391 $5,000
Q2 2023

Aug 08, 2023
SELL
$1.1 - $1.54 $115,533 - $161,746
-105,030 Reduced 90.41%
11,135 $13,000
Q1 2023

May 11, 2023
SELL
$1.19 - $2.09 $10,720 - $18,828
-9,009 Reduced 7.2%
116,165 $146,000
Q4 2022

Feb 14, 2023
BUY
$1.67 - $2.35 $4,238 - $5,964
2,538 Added 2.07%
125,174 $233,000
Q3 2022

Nov 10, 2022
BUY
$1.81 - $2.76 $25,159 - $38,364
13,900 Added 12.78%
122,636 $237,000
Q2 2022

Aug 11, 2022
BUY
$1.34 - $5.34 $12,361 - $49,261
9,225 Added 9.27%
108,736 $226,000
Q1 2022

May 12, 2022
BUY
$4.58 - $6.8 $261 - $387
57 Added 0.06%
99,511 $456,000
Q4 2021

Feb 10, 2022
BUY
$5.23 - $7.18 $4,837 - $6,641
925 Added 0.94%
99,454 $639,000
Q3 2021

Nov 12, 2021
BUY
$5.94 - $8.75 $34,410 - $50,688
5,793 Added 6.25%
98,529 $610,000
Q2 2021

Aug 05, 2021
SELL
$7.54 - $9.79 $54,665 - $70,977
-7,250 Reduced 7.25%
92,736 $742,000
Q1 2021

May 06, 2021
BUY
$4.76 - $11.25 $12,495 - $29,531
2,625 Added 2.7%
99,986 $964,000
Q4 2020

Feb 10, 2021
BUY
$2.43 - $5.42 $25,237 - $56,292
10,386 Added 11.94%
97,361 $470,000
Q3 2020

Nov 12, 2020
SELL
$2.3 - $3.72 $23,646 - $38,245
-10,281 Reduced 10.57%
86,975 $217,000
Q2 2020

Aug 13, 2020
BUY
$1.33 - $3.63 $26,361 - $71,950
19,821 Added 25.6%
97,256 $301,000
Q4 2019

Feb 05, 2020
SELL
$1.3 - $2.72 $12,912 - $27,017
-9,933 Reduced 11.37%
77,435 $157,000
Q3 2019

Oct 23, 2019
BUY
$1.93 - $4.21 $12,313 - $26,859
6,380 Added 7.88%
87,368 $205,000
Q2 2019

Aug 14, 2019
BUY
$2.05 - $4.32 $33,943 - $71,530
16,558 Added 25.7%
80,988 $350,000
Q1 2019

May 01, 2019
SELL
$1.79 - $3.12 $2,532 - $4,414
-1,415 Reduced 2.15%
64,430 $135,000
Q4 2018

Jan 31, 2019
BUY
$2.24 - $3.9 $46,264 - $80,550
20,654 Added 45.7%
65,845 $169,000
Q3 2018

Nov 07, 2018
BUY
$3.58 - $4.9 $358 - $490
100 Added 0.22%
45,191 $176,000
Q2 2018

Aug 06, 2018
SELL
$4.43 - $5.14 $8,638 - $10,023
-1,950 Reduced 4.15%
45,091 $215,000
Q1 2018

May 02, 2018
SELL
$4.65 - $5.9 $9,207 - $11,682
-1,980 Reduced 4.04%
47,041 $245,000
Q3 2017

Nov 06, 2017
BUY
$4.35 - $5.25 $213,241 - $257,360
49,021
49,021 $257,000

Others Institutions Holding CMRX

# of Institutions
77
Shares Held
39.4M
Call Options Held
243K
Put Options Held
110K
View Full List

About CHIMERIX INC

CMRX Quotes by TradingView
  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $748M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email